Long-term efficacy and safety of etentamig, a B-cell maturation antigen (BCMA) bispecific antibody in patients with relapsed/refractory multiple myeloma (RRMM). Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Baljevic, Muhamed
  • Voorhees, Peter M
  • Rodriguez Valdes, Cesar
  • D'Souza, Anita
  • Chung, Alfred
  • Lichtman, Eben I
  • Safah, Hana
  • Weisel, Katja C
  • Vij, Ravi
  • Mian, Hira
  • Magen, Hila
  • Searle, Emma
  • McKay, John T
  • Korde, Neha
  • Chhabra, Saurabh
  • Svensson, Anders
  • Pothacamury, Rajvineeth Kumar
  • Talati, Chetasi
  • Doerr, Thomas
  • Kumar, Shaji

publication date

  • June 2025